Geron reported $120.13M in Loan Capital for its fiscal quarter ending in June of 2026.





Loan Capital Change Date
Amgen USD 51.86B 27M Jun/2026
Bio Techne USD 200M 60M Mar/2026
Cassava Sciences USD 0 0 Dec/2024
Cytokinetics USD 248.2M 993K Jun/2026
Genmab DKK 4.96B 28M Jun/2026
Geron USD 120.13M 298K Jun/2026
Gilead Sciences USD 20.86B 1.27B Mar/2026
Incyte USD 28.42M 994K Jun/2026
MacroGenics USD 68.71M 1.29M Mar/2026
Novartis USD 37.49B 42M Jun/2026
Novavax USD 246.3M 200K Dec/2025